Neuropeptide Y1 receptor NPY1R: discovery of naturally occurring human genetic variants governing gene expression in cella as well as pleiotropic effects on autonomic activity and blood pressure in vivo. (DOI:10.1016/j.jacc.2009.05.035);Neuropeptide Y1 Receptor NPY1R. Discovery of Naturally Occurring Human Genetic Variants Governing Gene Expression In Cella as Well as Pleiotropic Effects on Autonomic Activity and Blood Pressure In Vivo

Journal of the American College of Cardiology

Volumn 54, Issue 10, 2009, Pages 944-954

  Wang, Lei ^a   Rao, Fangwen ^a   Zhang, Kuixing ^a   Mahata, Manjula ^a   Rodriguez Flores, Juan L ^a   Fung, Maple M ^a,c   Waalen, Jill ^d   Cockburn, Myles G ^e   Hamilton, Bruce A ^a   Mahata, Sushil K ^a,c   O'Connor, Daniel T ^a,b,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

genetics; hypertension; neuropeptide

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NEUROPEPTIDE Y1 RECEPTOR;

3' UNTRANSLATED REGION; ADRENERGIC ACTIVITY; ALLELE; ARTICLE; CARDIOVASCULAR DISEASE; COLD STRESS; DIASTOLIC BLOOD PRESSURE; DISEASE PREDISPOSITION; ENVIRONMENTAL STRESS; FEMALE; GENE EXPRESSION; GENE LOCUS; GENE SEQUENCE; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HOMOZYGOTE; HUMAN; HYPERTENSION; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PLEIOTROPY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ALIGNMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SITE DIRECTED MUTAGENESIS; SYSTOLIC BLOOD PRESSURE;

EID: 68949191193     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.09.001     Document Type: Erratum

References (36)

1. O'Connor D.T., Insel P.A., Ziegler M.G., et al. Heredity and the autonomic nervous system in human hypertension. Curr Hypertens Rep 2 (2000) 16-22
2. Rao F., Zhang L., Wessel J., et al. Tyrosine hydroxylase, the rate-limiting enzyme in catecholamine biosynthesis: discovery of common human genetic variants governing transcription, autonomic activity, and blood pressure in vivo. Circulation 116 (2007) 993-1006
3. Takiyyuddin M.A., Brown M.R., Dinh T.Q., et al. Sympatho-adrenal secretion in humans: factors governing catecholamine and storage vesicle peptide co-release. J Auton Pharmacol 14 (1994) 187-200
4. az-Cabiale Z., Parrado C., Rivera A., et al. Galanin-neuropeptide Y (NPY) interactions in central cardiovascular control: involvement of the NPYY1 receptor subtype. Eur J Neurosci 24 (2006) 499-508
5. Deltondo J., Por I., Hu W., et al. Associations between the human growth hormone-releasing hormone- and neuropeptide-Y-immunoreactive systems in the human diencephalon: a possible morphological substrate of the impact of stress on growth. Neuroscience 153 (2008) 1146-1152
6. Michalkiewicz M., Zhao G.Q., Jia Z., Michalkiewicz T., and Racadio M.J. Central neuropeptide Y signaling ameliorates N(omega)-nitro-L-arginine methyl ester hypertension in the rat through a Y1 receptor mechanism. Hypertension 45 (2005) 780-785
7. Zhou Z.F., Zhu G.S., Hariri A.R., et al. Genetic variation in human NPY expression affects stress response and emotion. Nature 452 (2008) 997-1001
8. Beck B., and Max J.P. Neuropeptide Y in the arcuato-paraventricular pathway and diet selection in the vasopressin-deficient Brattleboro rat. Brain Res Bull 76 (2008) 454-457
9. Eva C., Serra M., Mele P., Panzica G., and Oberto A. Physiology and gene regulation of the brain NPY Y1 receptor. Front Neuroendocrinol 27 (2006) 308-339
10. Kennedy B., Shen G.H., and Ziegler M.G. Neuropeptide Y-mediated pressor responses following high-frequency stimulation of the rat sympathetic nervous system. J Pharmacol Exp Ther 281 (1997) 291-296
11. Cavadas C., Cefai D., Rosmaninho-Salgado J., et al. Deletion of the neuropeptide Y (NPY) Y1 receptor gene reveals a regulatory role of NPY on catecholamine synthesis and secretion. Proc Natl Acad Sci USA 103 (2006) 10497-10502
12. O'Connor D.T., Kailasam M.T., Kennedy B.P., Ziegler M.G., Yanaihara N., and Parmer R.J. Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension. J Hypertens 20 (2002) 1335-1345
13. Zhang L., Rao F., Wessel J., et al. Functional allelic heterogeneity and pleiotropy of a repeat polymorphism in tyrosine hydroxylase: prediction of catecholamines and response to stress in twins. Physiol Genomics 19 (2004) 277-291
14. Cockburn M., Hamilton A., Zadnick J., Cozen W., and Mack T.M. The occurrence of chronic disease and other conditions in a large population-based cohort of native Californian twins. Twin Res 5 (2002) 460-467
15. Waalen J., Felitti V., Gelbart T., Ho N.J., and Beutler E. Prevalence of coronary heart disease associated with HFE mutations in adults attending a health appraisal center. Am J Med 113 (2002) 472-479
16. Schork N.J., Nath S.K., Fallin D., and Chakravarti A. Linkage disequilibrium analysis of biallelic DNA markers, human quantitative trait loci, and threshold-defined case and control subjects. Am J Hum Genet 67 (2000) 1208-1218
17. Schork N.J. Power calculations for genetic association studies using estimated probability distributions. Am J Hum Genet 70 (2002) 1480-1489
18. Rana B.K., Insel P.A., Payne S.H., et al. Population-based sample reveals gene-gender interactions in blood pressure in White Americans. Hypertension 49 (2007) 96-106
19. Tenesa A., Knott S.A., Carothers A.D., and Visscher P.M. Power of linkage disequilibrium mapping to detect a quantitative trait locus (QTL) in selected samples of unrelated individuals. Ann Hum Genet 67 (2003) 557-566
20. Conen D., and Bamberg F. Noninvasive 24-h ambulatory blood pressure and cardiovascular disease: a systematic review and meta-analysis. J Hypertens 26 (2008) 1290-1299
21. Cui J.S., Hopper J.L., and Harrap S.B. Antihypertensive treatments obscure familial contributions to blood pressure variation. Hypertension 41 (2003) 207-210
22. Wu J., Kraja A.T., Oberman A., et al. A summary of the effects of antihypertensive medications on measured blood pressure. Am J Hypertens 18 (2005) 935-942
23. Herrmann V., Buscher R., Go M.M., et al. Beta2-adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in whites and African Americans. Am J Hypertens 13 (2000) 1021-1026
24. Brinton T.J., Kailasam M.T., Wu R.A., et al. Arterial compliance by cuff sphygmomanometer. Application to hypertension and early changes in subjects at genetic risk. Hypertension 28 (1996) 599-603
25. Rao F., Wen G., Gayen J.R., et al. Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension. Circulation 115 (2007) 2271-2281
26. Almasy L., and Blangero J. Multipoint quantitative-trait likage analysis in general pedigrees. Am J Hum Genet 62 (1998) 1198-1211
27. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
28. Zaitlen N.A., Kang H.M., Feolo M.L., Sherry S.T., Halperin E., and Eskin E. Inference and analysis of haplotypes from combined genotyping studies deposited in dbSNP. Genome Res 15 (2005) 1594-1600
29. Nyholt D.R. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74 (2004) 765-769
30. Chen Y., Rao F., Das M., et al. Common, naturally occurring human genetic variation in the 3′-untranslated region of the secretory protein chromogranin A (CHGA) determines autonomic circulatory regulation and hypertension. J Am Coll Cardiol 52 (2008) 1468-1481
31. Naveilhan P., Hassani H., Lucas G., et al. Reduced antinociception and plasma extravasation in mice lacking a neuropeptide Y receptor. Nature 409 (2001) 513-517
32. Herzog H., Hort Y.J., Ball H.J., Hayes G., Shine J., and Selbie L.A. Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proc Natl Acad Sci USA 89 (1992) 5794-5798
33. Cavadas C., Waeber B., Pedrazzini T., et al. NPY Y1 receptor is not involved in the hemodynamic response to an acute cold pressor test in mice. Peptides 28 (2007) 315-319
34. Sethupathy P., Borel C., Gagnebin M., et al. Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3′ untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am J Hum Genet 81 (2007) 405-413
35. Zhang L., Rao F., Zhang K., et al. Discovery of common human genetic variants of GTP cyclohydrolase 1 (GCH1) governing nitric oxide, autonomic activity, and cardiovascular risk. J Clin Invest 117 (2007) 2658-2671
36. Boomsma D., Busjahn A., and Peltonen L. Classical twin studies and beyond. Nat Rev Genet 3 (2002) 872-882